Morningside is a Newton, Massachusetts–based venture capital firm founded in 1986 that makes long-term venture equity investments in companies developing novel science and technology solutions across life sciences, digital health, AI, materials and related sectors. The firm partners with founders and management teams from early and growth stages and emphasizes ethical practices and collaborative company-building over extended investment horizons. Its investment activities span healthcare, biotech, enterprise technology and adjacent innovation domains with a global orientation. Morningside also engages in charitable initiatives linked to education, research and healthcare institutions. The firm operates within the U.S. and broader international markets and is part of a broader private investment group with historical roots tied to the Chan family’s financial interests.